KOCAA
RYTM icon

Knights of Columbus Asset Advisors’s Rhythm Pharmaceuticals RYTM Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2M Buy
18,043
+2,454
+16% +$222K 0.1% 212
2026
Q1 		$1.36M Buy
15,589
+5,275
+51% +$513K 0.08% 234
2025
Q4 		$1.1M Buy
+10,314
New +$1.09M 0.06% 250

Other funds holding RYTM

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
AL
Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $29.3B AUM 38.15% 1-Year Est. Return

Knights of Columbus Asset Advisors's RYTM Position: Q2 2026 in Review

Knights of Columbus Asset Advisors increased its Rhythm Pharmaceuticals (RYTM) stake by 16% in Q2 2026, buying an estimated $222K and bringing the position to 18,043 shares worth $2M. The position accounts for 0.1% of the portfolio, ranked #212.

Knights of Columbus Asset Advisors first reported a position in RYTM in Q4 2025 and has held it in 3 quarters since. 63 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Knights of Columbus Asset Advisors held 18,043 shares of Rhythm Pharmaceuticals worth $2M as of Q2 2026.
  • Knights of Columbus Asset Advisors bought 2,454 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $222K.
  • Rhythm Pharmaceuticals made up 0.1% of Knights of Columbus Asset Advisors's portfolio in Q2 2026, its #212 holding.
  • Knights of Columbus Asset Advisors first reported a position in Rhythm Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 63 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.